Sentences with phrase «chronic kidney disease patient»

Chronic kidney disease patient depression numbers may be higher due to the presence of the same simultaneously occurring conditions that resulted in progressive kidney disease, such as diabetes and atherosclerotic vascular disease, one of the researchers noted.

Obesity increases a chronic kidney disease patient's risk of developing kidney failure, but the mechanism underlying this connection has remained unclear.

Based on this review, they suggest a «probable» association between vitamin D levels and birth weight, dental caries in children, maternal vitamin D levels at term and parathyroid hormone levels in chronic kidney disease patients requiring dialysis, but «further studies and better designed trials are needed to draw further conclusions.»

«Lowering salt intake improves heart, kidney health of chronic kidney disease patients.»

This is why a restriction of protein intake is often recommended to chronic kidney disease patients to help prevent further functional decline.

Not exact matches

He has published seminal works on blood pressure management through his role in the BPLTTC and played leading roles in a series of trials that define the clinical management of patients with diabetes and chronic kidney disease.

Led by Stella K. Kang, a radiologist with the Department of Radiology at the New York School of Medicine, the study was designed to compare the effectiveness of a treatment algorithm for small renal tumors incorporating the nephrometry score, a renal tumor anatomy scoring system developed by urologists, with the current standard of uniformly recommended partial nephrectomy in patients with mild - to - moderate chronic kidney disease (CKD).

«These findings suggested that patient information materials aimed at patients with chronic kidney disease are pitched well above the average patient's literacy level, so that most patients wouldn't be able to read and understand the health messages,» Webster said.

He says patients with diabetes and chronic kidney disease are among the most vulnerable to sustain acute kidney injury when hospitalized.

A new study published in the Journal of the American Medical Association found depressed patients with chronic kidney disease did not benefit from a common antidepressant.

Medicare spending for patients with chronic kidney disease aged 65 and older exceeded $ 50 billion in 2013 and represented 20 percent of all Medicare spending in that age group.

«The majority of patients with chronic kidney disease, particularly those in the more advanced stages who require dialysis, exhibited some degree of loss of their sense of smell, which correlated with reduced nutritional status,» says Teodor Paunescu, PhD, of the MGH Division of Nephrology, corresponding author of the study.

In patients with chronic kidney disease who are not on dialysis, ACEIs and ARBs slow the progression of diabetic nephropathy and reduce cardiovascular risk.

Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.

Richard J. McManus, F.R.C.G.P., of the University of Oxford, and colleagues randomly assigned 552 patients with hypertension and a history of stroke, coronary heart disease, diabetes, or chronic kidney disease to self - monitoring of blood pressure combined with an individualized self - titration algorithm or a control group (patients received usual care consisting of seeing their health care clinician for routine blood pressure measurement and adjustment of medication if necessary).

Chronic kidney disease stage 2 or more was present in one third of patients.

Editorial: Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

About 52 percent of patients had moderate chronic kidney disease (CKD) or worse.

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l - year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA.

They found that patients from this group who required admission to intensive or critical care units after surgery were more likely to have a history of chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, chronic kidney disease, or suffering blood loss of more than 1,000 milliliters during surgery or requiring vasopressors (medications that raise low blood pressure) during surgery.

«Patients with chronic kidney disease need to be aware of the potential for higher potassium content in sodium - reduced foods, as they are educated to follow a low sodium diet and may inadvertently choose sodium - reduced foods without realizing the risk of an increased potassium load from additives,» she said.

That paper reported that two - thirds of Type 2 diabetic men with chronic kidney disease have low testosterone levels and that among patients on dialysis, a remarkable 90 percent have low testosterone.

For this study, the researchers used data from a population of patients with both diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 15 years.

Hypertension is the most important treatable risk factor for cardiovascular disease, and while it is especially common in the elderly and in patients with chronic kidney disease (CKD), these are the least studied groups in randomized controlled trials examining the health effects of lowering blood pressure.

Patients with chronic kidney disease (CKD) are at increased risk of developing heart failure and other cardiovascular diseases.

In a patient with chronic kidney disease, the extent of their renal fibrosis usually predicts progression to end - stage kidney disease.

Of the 1,000 patients included in this analysis, 60 percent were male and the average age was 61; 49 percent had cardiac disease, 41 percent diabetes, 30 percent chronic kidney disease and 17 percent sleep apnea.

Investigators led by Suma Prakash, MD, FRCPC, MSc (Case Western Reserve University) wondered whether a model called the «behavioral stage of change» model, which was originally used to help people quit smoking, might help patients with chronic kidney disease take action and make decisions about their dialysis options.

«Patients with chronic kidney disease may want to pay more attention to diet consumption of acid rich foods to reduce progression to kidney failure, in addition to employing recommended guidelines such as taking kidney - sparing medication and avoiding kidney toxins,» said Dr. Banerjee.

For patients with chronic kidney disease, diets with a high acid content may increase their risk of developing kidney failure.

The discovery that elevated suPAR levels are a reliable predictor of future chronic kidney disease therefore was exciting news, because it signaled the approach of a day when clinicians will be able to track their patients» suPAR levels just as they now track cholesterol levels — and to intervene to control impending kidney disease when suPAR levels rise.

«Many patients who suffer from untreatable chronic diseases, including heart and kidney diseases, are in waiting lists for limited organ transplantation.

«We analyzed these small molecules in the blood and urine of non-diabetic patients with chronic kidney disease and compared the results to samples obtained from a group of healthy individuals,» said Stein Hallan, M.D., first author of the study published in EBioMedicine.

«Many patients show signs of chronic kidney disease before diabetes diagnosis: New insights from VA study could bolster early detection.»

The team also investigated the risk of infection while taking into account the duration of current or former statin use, 90 - day cumulative dose, and specific sub-groups of patients who were prescribed statins for different chronic conditions like previous myocardial infarction, peripheral arterial disease, chronic heart failure, chronic kidney disease, and diabetes.

«Metabolites altered in chronic kidney disease: Patients» samples reveal abnormality in cells» energy centers.»

In patients with chronic kidney disease (CKD), atherosclerosis is exceedingly common and contributes to the development of heart disease, which is the leading cause of death in this group.

There should be a rethink in how doctors talk to some patients with reduced kidney health, replacing the term «chronic kidney disease» (CKD) with different bands of kidney age, according to a group of experts writing in the...

Among patients with hypertension who received the automated phone calls, those who also had cardiovascular disease, chronic kidney disease and diabetes were up to 8.4 percent more likely to achieve better blood pressure control than those who did not have these conditions.

Dr. Diamantidis» research interests include the use of mobile technologies to promote patient engagement in chronic disease, person - centered chronic kidney disease care, patient safety, and health disparities in kidney disease.

Alterations of Hematological Parameters, Hemoglobin and Hematocrit With Liver Enzymes, Aspartate Transaminase and Alanine Transaminase Among Patients With Chronic Kidney Disease Undergoing Hemodialysis in Aljouf Region, Saudi Arabia

Results from the study showed that non-dialysis chronic kidney disease (CKD) patients that carried out combined and aerobic exercise 3 times a week for 12 weeks were found to be significantly stronger, had bigger leg muscles, and better cardiorespiratory fitness.

Among the 50 trials, 30 were primary prevention trials (general populations, smokers and workers exposed to asbestos, patients with oesophageal dysplasia, male physicians, patients with non-melanoma skin cancer, postmenopausal women, patients undergoing chronic haemodialysis, patients with end stage renal disease, ambulatory elderly women with vitamin D insufficiency, patients with chronic renal failure, older people with femoral neck fractures, patients with diabetes mellitus, elderly women with a low serum 25 - hydroxyvitamin D concentration, health professionals, people with a high fasting plasma total homocysteine concentration, or kidney transplant recipients), and 20 were secondary prevention trials (patients with cardiovascular disease, coronary heart disease, acute myocardial infarction, unstable angina, transient ischaemic attack, stroke, angiographically proved coronary atherosclerosis, vascular disease, or aortic valve stenosis).

July 14, 2015 Investigational drug prevents life - threatening side effects of kidney disease treatment A yearlong study of more than 300 patients found that the investigational drug patiromer can reduce elevated blood - potassium levels — a common side effect of drugs essential in the treatment of chronic diabetic kidney disease.

Both patient groups tended to be equally unhealthy, but PPI users had a 39 percent higher risk of chronic kidney disease, the researchers said.

Limited research exists on the impact of exercise in patients with chronic kidney disease (CKD), and which exercise is more beneficial for CKD patients is unclear.

SODIUM EXCRETION AND RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH KIDNEY DISEASE A second study cited by the CDC under the consistency criteria, «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years folloDISEASE IN PATIENTS WITH KIDNEY DISEASE A second study cited by the CDC under the consistency criteria, «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follPATIENTS WITH KIDNEY DISEASE A second study cited by the CDC under the consistency criteria, «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years followKIDNEY DISEASE A second study cited by the CDC under the consistency criteria, «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years folloDISEASE A second study cited by the CDC under the consistency criteria, «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follodisease in patients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follpatients with chronic kidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years followkidney disease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follodisease» 7 included 3757 subjects with chronic kidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years followkidney disease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follodisease (CKD), 55 percent males, who experienced 804 CVD events during 6.8 years follow - up.

Mills KT and others: «Sodium excretion and risk of cardiovascular disease in patients with chronic kidney disease» JAMA 2016 May 24 - 31; 31 (20): 2200 - 10.

The DIVINe study randomized two groups of patients with chronic kidney disease (CKD) to either placebo or vitamin B supplements with the hope of slowing down the progression of kidney disease.

Copper deficiency may occur in preterm infants, infants fed with cow's milk formula, chronic alcoholics, individuals with cystic fibrosis, Crohn's or celiac disease or other small intestinal disorder affecting absorption of copper, gastric bypass (bariatric surgery for weight loss)[3], kidney patients on hemodialysis, those who take zinc supplements or a metal binder penicillamine and in individuals with hereditary disorders of copper metabolism [1].